> However, I worry you want 23andMe to independently validate each of these results before informing customers about them. Worse still would be a demand that the company validate the results with its specific testing kit. It would be cost-prohibitive even for a single company like 23andMe. It would destroy any possibility of competition; even if one company did it, new startups would not be able to.

Looks like a case of the FDA doing what it does best--ensuring the task of medical innovation remains with big pharma, and leaving Americans stunned at the results.